Journal of Nuclear Medicine: 60 (3)

Index by author

March 1, 2019; Volume 60,Issue 3

This Month in JNM

You have access
This Month in JNM
Journal of Nuclear Medicine March 1, 2019, 60 (3) 6A;

Leadership Perspectives

You have access
Discussions with Leaders: A Conversation between Simon Cherry and Johannes Czernin
Simon R. Cherry and Johannes Czernin

Journal of Nuclear Medicine March 1, 2019, 60 (3) 295-298;

The State of the Art

You have access
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Ramsey D. Badawi, Hongcheng Shi, Pengcheng Hu, Shuguang Chen, Tianyi Xu, Patricia M. Price, Yu Ding, Benjamin A. Spencer, Lorenzo Nardo, Weiping Liu, Jun Bao, Terry Jones, Hongdi Li and Simon R. Cherry

Journal of Nuclear Medicine March 1, 2019, 60 (3) 299-303; DOI: https://doi.org/10.2967/jnumed.119.226498

Continuing Education

You have access
An Imager’s Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on ¹⁸F-FDG PET, with CT and MRI Correlates
Hwan Lee, Jillian W. Lazor, Reza Assadsangabi and Jagruti Shah

Journal of Nuclear Medicine March 1, 2019, 60 (3) 304-311; DOI: https://doi.org/10.2967/jnumed.118.214312

Clinical

Oncology
- You have access
  Evaluation of ¹¹C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma
  Christopher L. Tinkle, Elizabeth C. Duncan, Mikhail Doubrovin, Yuanyuan Han, Yimei Li, Hyun Kim, Alberto Broniscer, Scott E. Snyder, Thomas E. Merchant and Barry L. Shulkin
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 312-319; DOI: https://doi.org/10.2967/jnumed.118.212514
- INVITED PERSPECTIVE
  - You have access
    Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans
    Robert K. Doot
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 320-321; DOI: https://doi.org/10.2967/jnumed.118.220913
- Open Access
  Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of ¹⁸F-Fluoride Metabolic Flux Than with Measurement of ¹⁸F-Fluoride PET/CT SUV?
  Gurdip K. Azad, Musib Siddique, Benjamin Taylor, Adrian Green, Jim O’Doherty, Joanna Gariani, Glen M. Blake, Janine Mansi, Vicky Goh and Gary J.R. Cook
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 322-327; DOI: https://doi.org/10.2967/jnumed.118.208710
- You have access
  What ¹⁸F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
  Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
- FEATURED ARTICLE OF THE MONTH
  - You have access
    ¹⁸F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
    Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L. Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D. Wolchok and Wolfgang A. Weber
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 335-341; DOI: https://doi.org/10.2967/jnumed.118.213652
- You have access
  Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions
  Simone Schenke, Philipp Seifert, Michael Zimny, Thomas Winkens, Ina Binse and Rainer Görges
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 342-347; DOI: https://doi.org/10.2967/jnumed.118.211912
- BRIEF COMMUNICATION
  - You have access
    Hexokinase-2 Expression in ¹¹C-Methionine–Positive, ¹⁸F-FDG–Negative Multiple Myeloma
    Stefan Kircher, Antje Stolzenburg, Klaus Martin Kortüm, Malte Kircher, Matteo Da Via, Samuel Samnick, Andreas K. Buck, Hermann Einsele, Andreas Rosenwald and Constantin Lapa
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 348-352; DOI: https://doi.org/10.2967/jnumed.118.217539
Basic
- FEATURED BASIC SCIENCE ARTICLE
  - Open Access
    Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
    Thomas A. Burley, Chiara Da Pieve, Carlos D. Martins, Daniela M. Ciobota, Louis Allott, Wim J.G Oyen, Kevin J. Harrington, Graham Smith and Gabriela Kramer-Marek
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 353-361; DOI: https://doi.org/10.2967/jnumed.118.216069

Theranostics

Clinical
- Open Access
  Detection Efficacy of ¹⁸F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
  Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka and Matthias Eiber
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.118.212233
- You have access
  Performance of ⁶⁸Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
  Sangwon Han, Chong Hyun Suh, Sungmin Woo, Yeon Joo Kim and Jong Jin Lee
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 369-376; DOI: https://doi.org/10.2967/jnumed.118.211706
- You have access
  Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
  Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller and Richard P. Baum
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 377-385; DOI: https://doi.org/10.2967/jnumed.118.215848
Translational
- FEATURED ARTICLE OF THE MONTH
  - Open Access
    ⁶⁸Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
    Frederik L. Giesel, Clemens Kratochwil, Thomas Lindner, Manfred M. Marschalek, Anastasia Loktev, Wencke Lehnert, Jürgen Debus, Dirk Jäger, Paul Flechsig, Annette Altmann, Walter Mier and Uwe Haberkorn
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.118.215913
- You have access
  Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog ¹⁷⁷Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
  Alexander W. Sauter, Rosalba Mansi, Ulrich Hassiepen, Lionel Muller, Tania Panigada, Stefan Wiehr, Anna-Maria Wild, Susanne Geistlich, Martin Béhé, Christof Rottenburger, Damian Wild and Melpomeni Fani
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 393-399; DOI: https://doi.org/10.2967/jnumed.118.207845
- You have access
  Evaluation of ¹¹¹In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
  Sangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, Donika Plyku, Zora Nováková, Mary Brummet, Bryan Wharram, Cyril Barinka, Robert Hobbs and Martin G. Pomper
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 400-406; DOI: https://doi.org/10.2967/jnumed.118.214403

Cardiology

Clinical
- INVITED PERSPECTIVE
  - You have access
    Quantitative Coronary Flow Capacity for Risk Stratification and Clinical Decision Making: Is It Ready for Prime Time?
    Marcelo F. Di Carli and Rory Hachamovitch
    
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 407-409; DOI: https://doi.org/10.2967/jnumed.118.219717
- Open Access
  Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
  K. Lance Gould, Nils P. Johnson, Amanda E. Roby, Tung Nguyen, Richard Kirkeeide, Mary Haynie, Dejian Lai, Hongjian Zhu, Monica B. Patel, Richard Smalling, Sal Arain, Prakash Balan, Tom Nguyen, Anthony Estrera, Stefano Sdringola, Mohammad Madjid, Angelo Nascimbene, Pranav Loyalka, Biswajit Kar, Igor Gregoric, Hazem Safi and David McPherson
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.118.211953

Molecular Imaging

Translational
- You have access
  Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
  Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit and Wouter B. Nagengast
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 418-423; DOI: https://doi.org/10.2967/jnumed.118.216556

Radiochemistry

Basic
- You have access
  Production of ¹⁵O for Medical Applications via the ¹⁶O(γ,n)¹⁵O Reaction
  Stacy L. Queern, Ryan Cardman, Christopher S. Loveless, Matthew R. Shepherd and Suzanne E. Lapi
  
  Journal of Nuclear Medicine March 1, 2019, 60 (3) 424-428; DOI: https://doi.org/10.2967/jnumed.118.215681

Physics and Instrumentation

You have access
Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction
Angel Torrado-Carvajal, Javier Vera-Olmos, David Izquierdo-Garcia, Onofrio A. Catalano, Manuel A. Morales, Justin Margolin, Andrea Soricelli, Marco Salvatore, Norberto Malpica and Ciprian Catana

Journal of Nuclear Medicine March 1, 2019, 60 (3) 429-435; DOI: https://doi.org/10.2967/jnumed.118.209288

Letters to the Editor

You have access
Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells
Jörg Kotzerke, Roswitha Runge, Anja Braune and Gerd Wunderlich

Journal of Nuclear Medicine March 1, 2019, 60 (3) 436; DOI: https://doi.org/10.2967/jnumed.118.220707
You have access
Reply: Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells
Orit Jacobson and Xiaoyuan Chen

Journal of Nuclear Medicine March 1, 2019, 60 (3) 436-437; DOI: https://doi.org/10.2967/jnumed.118.223453
You have access
Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks
James R. Duncan, Michael R. Lieber, Noritaka Adachi and Richard L. Wahl

Journal of Nuclear Medicine March 1, 2019, 60 (3) 437-438; DOI: https://doi.org/10.2967/jnumed.118.223461

Erratum

You have access
Erratum
Journal of Nuclear Medicine March 1, 2019, 60 (3) 438;

SNMMI Newsline

You have access
News: FDA Reviews NDA for ¹⁸F-FDOPA in Congenital Hyperinsulinism
Journal of Nuclear Medicine March 1, 2019, 60 (3) 7N;
You have access
News: SNMMI and SNMMI-TS 2019 Leadership Graduates
Journal of Nuclear Medicine March 1, 2019, 60 (3) 8N;
You have access
News from SNMMI Leadership: Thought Leaders to Gather at 2019 SNMMI Annual Meeting in Anaheim, CA
Virginia Pappas

Journal of Nuclear Medicine March 1, 2019, 60 (3) 9N;
You have access
From the Literature
Journal of Nuclear Medicine March 1, 2019, 60 (3) 10N-15N;

Main menu

User menu

Search

Index by author

This Month in JNM

Leadership Perspectives

The State of the Art

Continuing Education

Clinical

Oncology

INVITED PERSPECTIVE

FEATURED ARTICLE OF THE MONTH

BRIEF COMMUNICATION

Basic

FEATURED BASIC SCIENCE ARTICLE

Theranostics

Clinical

Translational

FEATURED ARTICLE OF THE MONTH

Cardiology

Clinical

INVITED PERSPECTIVE

Molecular Imaging

Translational

Radiochemistry

Basic

Physics and Instrumentation

Letters to the Editor

Erratum

SNMMI Newsline

In this issue

Issue highlights

Jump to